Blinding (or masking)
A way to prevent researchers, doctors and patients in a clinical trial from knowing which study group each patient is in so they cannot influence the results. The best way to do this is by sorting patients into study groups randomly. The purpose of 'blinding' or 'masking' is to protect against bias.
In a single-blind study, patients do not know which study group they are in (for example whether they are taking the experimental drug or a placebo). In a double-blind study, neither the patients nor the researchers/doctors know which study group the patients are in. In a triple-blind study, the patients, clinicians and the people carrying out the statistical analysis do not know which treatment patients had.